New remedies are needed as rates of multi-drug resistant TB rise.
As antibiotics lose their power to treat some forms of TB, interest in the antibacterial powers of curdlan is rising.
Plastic waste in Kampala, Uganda.
Omer Faruk Ozbil/Anadolu Agency via Getty Images
It’s important to look at the whole value chain in the plastics economy, starting with design of products that can be reused and recycled.
Nigeria provides an excellent lens to look at the genetic diversity of African people.
A new study hopes to produce a catalogue of human genetic variation and assess the burden of noncommunicable diseases in 100,000 adults in Nigeria.
A factor holding back African research is the lack of strong collaborative networks between African laboratories and institutions.
Drug discovery research in Africa receives modest but essential international funding through philanthropic foundations and selected pharmaceutical companies.
Molecular research like that conducted at the African Centre of Excellence for Genomics of Infectious Diseases in Nigeria is key to medical breakthroughs.
PIUS UTOMI EKPEI/AFP via Getty Images
Molecular research is expensive, but worth it because of the burden of disease that it could relieve.
Before the COVID pandemic, efforts to address the challenge of limited vaccine production on the continent yielded little success.
Mobile health interventions offer convenience, confidentiality, and privacy.
Mobile health or mHealth is an appealing way to reach adolescents because it offers opportunities to deliver and monitor health interventions at a much lower cost.
Nigeria’s nanotechnology journey has been slow.
BSIP/Universal Images Group via Getty Images
As a major contributor of knowledge, Nigeria could make giant strides in nanotechnology – which in turn could help various industries blossom.
The red mangrove is among the species already selected for genome sequencing.
The African BioGenome Project is a pan-African project that seeks to sequence Africa’s endemic and indigenous plants and animals.
There remains a crucial need for animal models to understand health and disease and to develop medicines.
Operating in crisis mode for COVID-19, TB, or any other health catastrophe is difficult to sustain.
Seyllou/AFP via Getty Images
In 2020 TB case detection fell by almost 20% and mortality rose for the first time in a decade. These setbacks are directly attributable to the COVID-19 pandemic.
Afrigen, a biotechnology company based in Cape Town, South Africa, is developing Africa’s first proprietary COVID-19 vaccine.
Kristin Palitza/picture alliance via Getty Images
With the manufacturing capacity and access to relevant technology, African countries can reduce their dependency on international manufacturers for vaccines.
Saponins from plants can destroy viruses and other microorganisms in the same way commercial soaps and detergents do.
Women have a valuable role to play across scientific disciplines - but can’t do this without proper support.
Katleho Seisa/Getty Images
Young academies, which generally represent early career scientists, fared far better than their senior counterparts - a promising sign for the future.
As a disease progresses, so too must the underlying data and reporting improve to manage the progression of the outbreak.
Africa has a growing promising cadre of smart and skilled health experts.
To attain a new health order, African governments need to bolster investment in research and development, innovation and manufacturing of health tools.
South Africa is seeing a spike in COVID-19 cases.
EMMANUEL CROSET/AFP via Getty Images
At this stage, we cannot say anything about the severity of cases with Omicron - either in primary or reinfections.
HIV prevalence in the Congo Basin is relatively low.
Yannick Tylle/ GettyImages
To be effective, vaccine formulas need to cover all emergent strains. But there are still plenty of unknowns.
Rift Valley Fever virus, 3D illustration.
Manufacturing is just one part of the vaccine ecosystem. It’s the health system that delivers vaccines and people must be willing to take them.
There’s an urgent need for therapeutics to complement vaccines.
Jakub Porzycki/NurPhoto via Getty Images
The need of the moment is for low- and middle-income countries to improve their own manufacturing capabilities.